Nuffield Division of Clinical Laboratory Sciences
Head of Division
About NDCLS
Our aim is to study the pathology of human disease from the molecular to systems level, and to translate our findings into treatments for human disorders.
Read moreLatest Publications
Phenotypic and molecular characterization of a serum-free miniature erythroid differentiation system suitable for high-throughput screening and single-cell assays.
Mettananda S. et al, (2018), Exp Hematol, 60, 10 - 20
Genome and epigenome engineering CRISPR toolkit for in vivo modulation of cis-regulatory interactions and gene expression in the chicken embryo.
Williams RM. et al, (2018), Development, 145
Editing an α-globin enhancer in primary human hematopoietic stem cells as a treatment for β-thalassemia.
Mettananda S. et al, (2017), Nat Commun, 8
Enasidenib induces acute myeloid leukemia cell differentiation to promote clinical response.
Amatangelo MD. et al, (2017), Blood, 130, 732 - 741
Enasidenib in mutant IDH2 relapsed or refractory acute myeloid leukemia.
Stein EM. et al, (2017), Blood, 130, 722 - 731
The Latest News
James Davies named as Lister Research Prize Fellow
23 June 2022
James Davies has been named as one of eight researchers selected for the 2022 Fellowship scheme.
Six new Associate Professor titles at RDM
14 June 2022
Graham Collins, Betty Raman, Susie Shapiro, Christopher Toepfer, Stephen Twigg, and Adam Wilkinson have all been awarded Associate Professor titles
Building on the pandemic experience
24 May 2022
Dr Susie Shapiro on her experience of working through the pandemic, and how she is building on it.